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Asymmetric Synthesis of (-)-7-Epiaustraline and (+)-1,7-Diepiaustraline 
 
Minyan Tang and Stephen G. Pyne* 
 
Department of Chemistry, University of Wollongong, Wollongong, New South Wales, 2522, Australia 
 
spyne@uow.edu.au 
 
Abstract: A diastereoselective and modular approach to the synthesis of the 3-hydroxymethyl-
2,3,5,6,7,7a-hexahydro-1H-pyrrolizine-1,2,7-triol structure, characteristic of several natural 
pyrrolizidine natural products has been developed.  This approach culminated in the synthesis of (-)-7-
epiaustraline and (+)-1,7-diepiaustraline.  The oxazolidinone group has been found to be a useful 
protecting group in the RCM reaction and, as part of a pyrrolo[1,2-c]oxazol-3-one ring system, has 
functioned as a stereo- and regio-directing group, in a key diastereoselective cis-dihydroxylation 
reaction and a regioselective nucleophilic ring-opening of a S,S-dioxo-dioxathiole. 
 
 
 
 
 
 
 
 
Dedicated to Prof. John Bremner on the occasion of his 60th birthday. 
     
2 
  
Alexine (1) was the first alkaloid to be isolated with the 3-hydroxymethyl-2,3,5,6,7,7a-hexahydro-1H-
pyrrolizine-1,2,7-triol structure in 1988.1 In the same year its 7a-epimer, australine (2), was isolated 
from the seeds of the Australian legume, Castanospermum australe.2  Later reports described the 
isolation of other epimers of 2 from these seeds.3  A recent re-investigation of these seed extracts 
confirmed the presence of the alkaloids 2-4 and revealed the isolation of three new alkaloids, the 2-O-
-D-glucopyranosyl derivative of 3 and the compounds 5 and 6.4  The latter two alkaloids were 
epimeric at C-7, with 6 having the same C-7, C-7a stereochemistry as casurine 7.5  Compound 6 is the 
first 7-epiaustraline alkaloid to be isolated.  While this honor was originally claimed for 7-
epiaustraline itself,3c synthetic studies by Denmark6 established that 7-epiaustraline was not a natural 
product and that the original investigators had isolated australine.   These alkaloids have been tested 
for their glycosidase inhibitory activities2,3c and recently on several - and -glucosidase enzymes and 
-L-fucosidase.4  Compounds 2, 5 and 7 and the 2-O--D-glucopyranosyl derivative of 3 and the 6-O-
-D-glucopyranosyl derivative of 7, were the most potent and specific enzyme inhibitors.  Other 
biological studies7 have revealed the potential of these and related polyhydroxylated pyrrolizidines as 
antiviral and anti-retroviral agents.7b,c  These interesting biological properties coupled with the 
polyfunctional and stereochemically rich nature of these compounds have attracted the attention of 
synthetic chemists resulting in the total synthesis of alexine,8 and its epimers,8,9 australine,10 and its 
epimers,6,9-11 and casuarine.12  
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Figure 1.  Structures of 3-hydroxymethyl pyrrolizidine 
  
We report here a new synthetic strategy for the preparation of these natural products, and their various 
stereoisomers, as shown in Figure 1.  This modular approach, which in principle allows access to all 
the stereoisomers of 3-hydroxymethyl-2,3,5,6,7,7a-hexahydro-1H-pyrrolizine-1,2,7-triol (A), is shown 
in Figure 2. 
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Figure 2.  Retrosynthetic analysis 
Aminolysis13-15 of the enantiomerically enriched cis- or trans-vinyl epoxide E, that is readily available 
in all configurational forms using the Sharpless epoxidation,15,16  with either R or S chiral allylic amine 
D,17  could regio- and diastereoselectively provide the corresponding 1,2-amino alcohol with any 
stereochemistry desired.   Protection of the amino alcohol functionality as the 2-oxazolidinone C 
followed by a ring-closing metathesis reaction13,15,18-20 should provide the conformationally rigid 
pyrrolo[1,2-c]oxazol-3-one structure B.  The bicyclic nature of B should allow for a stereochemically 
controlled cis-dihydroxylation of the 3,4-double bond of B, a problem that we15 and others18j,21 
experienced in the synthesis of (-)-swainsonine.  To test the feasibility of this approach we chose (+)-
1,7-diepiaustraline 8 and (-)-7-epiaustaline 9 as our target molecules (Figure 3).  These compounds 
have the 6,7-cis and 6,7-trans diol stereochemistry, respectively.  It was anticipated that by employing 
a oxozolidinone protecting group then the conformationally rigid pyrrolo[1,2-c]oxazol-3-one structure 
(F, Figure 3) obtained would allow for the introduction of these functionalities in a diastereoselective 
manner. 
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Figure 3. Target molecules 
 
 
The starting vinyl epoxide (+)-(2R, 3R)-10 was prepared from the corresponding Sharpless epoxy 
alcohol (94 % ee from 1H NMR analysis of its Mosher ester) via Swern oxidation followed by a 
Wittig-olefination reaction.13,15,22  A solution of the vinyl epoxide (+)-10 and the (S)-allylamine 1117 
(1.4 equiv) in acetonitrile was heated at 120 oC in a sealed tube using LiOTf (1.5 equiv) as a catalyst 
for 72 h.   This gave the amino alcohol (+)-12, along with no more than 2-3% of another diastereomer, 
in 98% yield via an SN2 ring opening.  The amino-alcohol (+)-12 was converted to the 
diastereomerically pure 2-oxazolidinone derivative (+)-13 in 79% yield using triphosgene under basic 
conditions.23   
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Scheme 1. Reagents and conditions: a) LiOTf, CH3CN, 120 
0C, sealed tube, 72 h; b) triphosgene, 
Et3N, DCM, RT, 2 h; c) Grubbs’ catalyst I, DCM, reflux, 44 h; d) K2OsO4
.H2O, NMO, acetone, H2O, 
RT, 24 h; e) Ac2O, pyridine, RT, 24 h; f) DDQ, DCM, H2O, RT, 2 h; g) NaOH, EtOH, 70 
0C, sealed 
7 
tube, 24 h; h) DIAD, PPh3, pyridine, 0 
0C, 2.5 h; i) Ac2O, pyridine, RT, 24 h; j) PdCl2, H2, MeOH, RT, 
1.5 h; k) Ac2O, pyridine, RT, 24 h; l) NaOMe, MeOH, RT, 15 h. 
 
We were then ready to try the ring-closing metathesis (RCM) of 13.  While 2-oxazolo[3,4-a]pyridin-3-
ones 18g,19a,20a-d,24 and their seven and eight18d,19b,e membered-ring analogues have been successfully 
prepared via RCM, the RCM of 3-allyl-4-vinyl-2-oxazolidinone to give pyrrolo[1,2-c]oxazol-3-one 
has been reported not to proceed at RT.18a   We found that the RCM of 13 using standard conditions,  
5-10 mol % of Grubbs I catalyst (benzylidenebis(tricyclohexylphosphine)ruthenium dichloride) in 
refluxing CH2Cl2 at high dilution (~4 mM)
13,15 for 20 h, gave low conversion to the desired 2,5-
dihydropyrrole 14. However, by initiating the reaction using 25 mol% Grubbs I catalyst and then 
adding a further 25 mol% catalyst after 24 h, then 14 could be isolated in 73% yield after a total of 48 
h of heating at reflux.   Compound (-)-14 was treated with 5 mol % K2OsO4.2H2O and NMO (2.1 
equiv),15 to effect cis-dihydroxylation (DH) of the double bond, giving diol (-)-15 in good yield (82%).  
Only one diastereomeric product was isolated, which was expected to arise from delivery of the two 
hydroxyl groups to the least hindered face of the 6,7-double bond in (-)-14.  Figure 4 shows a 
molecular model (PC Spartan Pro, AM1) of 14, the -face is more sterically demanding due to the 
pseudo-axial proton H7a and the -C-5 benzyloxymethyl substituent, that hinder the -face (convex 
face) to attack by the osmium reagent (Figure 4).  A similar argument has been proposed for the facial 
selectivity of DH reactions on related indolizines.15,18j,21  The absolute stereochemistry assigned to 14 
was unequivocally confirmed by its conversion to (+)-1,7-di-epiaustraline (8).  
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Figure 4. Molecular Model (PC Spartan Pro, AM1) of 14 (PMB group not shown). 
 
Attempts to deprotect the primary PMB ether in 14 under oxidative conditions with DDQ25 gave a 
poor yield of the desired primary alcohol due to the formation of several other products that could not 
be structurally identified.  The diacetate derivative 16 however was smoothly converted to the primary 
alcohol 17 in 88% yield.  Compound 17 was then converted to the pyrrolizidine-triacetate 20 in three 
synthetic steps.   Base hydrolysis of 16 followed by ion-exchange chromatography gave 18 which was 
cyclized to the desired pyrrolizidine ring system under Mitsunobu conditions26 in pyridine at 0 oC.  
This reaction resulted in a mixture of 19 and starting tetrol 18, which were readily separated as their 
peracetylated derivatives.  In this way the pyrrolizidine-triacetate 20 was obtained in 20% overall yield 
from 17, over the three synthetic steps.  The use of longer reaction times or other cyclization methods 
(e.g. CBr4, Ph3P)
15,27 did not result in improved yields of 20.  Compound 20 was then smoothly 
converted to the triacetate of (+)-1,7-diepiaustraline (22) by first hydrogenolysis of the primary benzyl 
ether group15,28 and then peracetylation in 84% overall yield.  Finally, methoxide catalysed removal of 
the secondary acetates of 22 gave (+)-1,7-diepiaustraline (8) in 92% yield. This sample had identical 
spectral characteristics to those reported in the literature for (+)-8,9c and its specific rotation ([]D24 
9 
+6.4 (c 0.7, MeOH), []D24 +8.6 (c 0.7, H2O)) closely matched that previously reported (lit.9c ([]D20 + 
4.7 (c 0.5, H2O)). 
Scheme 2 outlines the synthesis of (-)-7-epiaustraline (9).  This synthesis required inversion of the 
stereochemistry at C-7 in the pyrrolo[1,2-c]oxazol-3-one 15.   Thus 15 was converted to its cyclic-
sulfate 23 using thionyl chloride followed by oxidation of the resulting cyclic sulfite with catalytic 
ruthenium tetroxide (80% yield for the two-step conversion).29 Regioselective nucleophilic ring 
opening of the S,S-dioxo-dioxathiole ring of 15 with cesium benzoate,29,30 followed by an acid 
catalysed-hydrolysis gave the benzoate 24 in 56% yield. A small amount (ca 5%) of the other 
regioisomer could be detected from 1H NMR analysis of the crude reaction mixture, however this 
minor compound could not be isolated pure.  Nucleophilic attack on 23 would be expected to occur 
preferentially at C-7 since backside attack at C-6 would be more sterically demanding due to the -C-5 
benzyloxymethyl substituent.  Oxidative removal of the primary PMB ether in 24 using DDQ gave the 
corresponding primary alcohol 25 in 75% yield, without the need to protect the C-6 hydroxyl group. 
Base hydrolysis of the oxazolidinone ring gave the amino tetrol 26 in 61% yield.  Cyclization of 26 
under Mitsunobu conditions again proved problematic and after acetylation of the crude cyclization 
mixture, the desired triacetate 28 was isolated in 22% overall yield from 26.  This compound was 
readily converted to the known triacetate of (-)-7-epiaustraline (30) according to Scheme 2. This 
sample had identical spectral characteristics to those reported in the literature for (-)-30.3b,7a Base 
catalysed hydrolysis of 30 gave (-)-7-epiaustaline (9) that  had spectral data and a specific rotation 
([]D24 –14.1 (c 0.22, H2O)), almost identical to that reported in the literature (lit.6 []D20 –13.04 (c 
0.55, H2O, pH 8.37)). 
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Scheme 2. Reagents and conditions: a) (i) SOCl2, Et3N, DCM, 0 
0C, 30 min; (ii) RuCl3
.3H2O, NaIO4, 
CCl4:CH3CN:H2O = 2:2:3, RT, 2 h; b) (i) PhCOOH, Cs2CO3, DMF, 40 
0C, 23 h; (ii) H2SO4 (conc.), 
THF, H2O, RT, 18 h; c) DDQ, DCM, H2O, RT, 2 h; d) NaOH, EtOH, 70 
0C, 19 h; e) DIAD, PPh3, 
THF, 0 0C, 3 h; f) Ac2O, pyridine, RT, 21 h; g) PdCl2, H2, MeOH, RT, 1 h; h) Ac2O, pyridine, RT, 15 
h; i) K2CO3, MeOH, RT, 24 h. 
 
In summary, we have developed a diastereoselective and modular approach to the synthesis of the 3-
hydroxymethyl-2,3,5,6,7,7a-hexahydro-1H-pyrrolizine-1,2,7-triol structure, characteristic of several 
pyrrolizidine natural products.  The oxazolidinone group has been found to be a useful protecting 
group in the RCM reaction and, as part of a pyrrolo[1,2-c]oxazol-3-one ring system, has functioned as 
a stereo- and regio-directing group, in a key diastereoselective cis-dihydroxylation reaction and a 
11 
regioselective nucleophilic ring-opening of a S,S-dioxo-dioxathiole.  The application of this strategy to 
the synthesis of the alkaloids in the australine family (2-6) is currently in progress. 
 
12 
Experimental Section 
 (+)-6-(4-Methoxyphenyl)methoxy-3R-[(1S-phenylmethoxymethyl)-2-propenyl]amino-1-hepten-
4-ol (12).  To a mixture of 10 (195 mg, 0.833 mmol) and 1117 (202 mg, 1.144 mmol) in dry 
acetonitrile (1 mL), in a thick walled glass tube, was added lithium triflate (195 mg, 1.249 mmol). The 
vessel was flushed with nitrogen and sealed and then stirred and heated at 120 0C for 3 days. The 
mixture was then cooled to RT and all volatiles were removed in vacuo to give a dark sticky oil which 
was purified by column chromatography (0%-10% methanol/DCM) to give compound 12 (334 mg, 
98%) as a yellow oil.  []D22 +3.8 (c 2.7, CHCl3); 1H NMR  7.34-7.27 (m, 5H), 7.23 (d, 2H, J 8.7 
Hz), 6.86 (d, 2H, J 8.7 Hz), 5.66 (ddd, 1H, J 8.4, 10.2, 17.1 Hz), 5.54 (dddd, 1H, J 1.8, 6.0, 9.9, 15.9 
Hz), 5.25-5.09 (m, 4H, 2x =CH2), 4.51 (s, 2H), 4.43 (s, 2H), 3.79 (s, 3H), 3.79 (m, 1H), 3.66-3.59 (m, 
2H), 3.47-3.39 (m, 3H), 3.12 (dd, 1H, J 4.2, 8.1 Hz), 1.77-1.59 (m, 2H); 13C NMR  159.0 (C, Ar), 
137.9 (C, Ar), 137.4 (CH), 136.0 (CH), 130.1 (C, Ar), 129.2 (CH, Ar), 128.3 (CH, Ar), 127.5 (CH, 
Ar), 127.5 (CH, Ar), 118.1 (CH2), 118.0 (CH2), 113.7 (CH, Ar), 73.2 (CH2), 73.0 (CH2), 72.8 (CH2), 
72.0 (CH), 68.3 (CH2), 62.4 (CH), 57.9 (CH), 55.3 (CH3), 33.0 (CH2); MS (CI +ve) m/z 412 (M+1
+, 
100%); HRMS (CI +ve) Calcd for C25H34NO4 (MH
+) 412.2488. Found: 412.2478. 
 
 (+)-4S-Ethenyl-5R-[2-(4-Methoxyphenyl)methoxy]ethyl-3-(1S-phenylmethoxymethyl-2-
propenyl)-1,3-oxazolidin-2-one (13).  A solution of 12 (618 mg, 1.503 mmol) in dry DCM (50 mL) 
was cooled to 0 0C and triethylamine (852 mg, 1.2 mL, 8.416 mmol) was added. A solution of 
triphosgene (268 mg, 0.902 mmol) in dry DCM (3 mL) was cooled to 0 0C and was then added to the 
above amine solution at 0 0C. TLC analysis (40% EtOAc/petrol) indicated complete disappearance of 
the compound 12 after 2 h. The reaction was quenched with water (50 mL). The aqueous portion was 
extracted with DCM (4x). The combined organic portions were dried (MgSO4) and filtered and the 
13 
solvent was evaporated to give a yellow semi-solid. Chromatography of the residue eluting with (20%-
40%) EtOAc/petrol gave compound 13 (520 mg, 79%) as a pale yellow oil.  []D25 +18.3 (c 2.5, 
CHCl3); 
1H NMR  7.34-7.30 (m, 5H), 7.24 (d, 2H, J 8.7 Hz), 6.87 (d, 2H, J 8.7 Hz), 5.87-5.66 (m, 
2H), 5.24 (dt, 1H, J 17.1, 1.2 Hz), 5.24 (dd, 1H, J 1.2, 10.8 Hz), 5.18 (dt, 1H, J 10.2, 1.2 Hz), 5.13 (dt, 
1H, J 17.7, 1.2 Hz), 4.70 (ddd, 1H, J 3.9, 8.1, 9.3 Hz), 4.59 (d, 1H, J 12.0 Hz), 4.47 (d, 1H, J 11.7 Hz), 
4.44 (d, 1H, J 11.4 Hz), 4.39 (d, 1H, J 11.4 Hz), 4.32 (dtt, 1H, J 5.4, 1.2, 9.0 Hz), 4.21 (t, 1H, J 8.7 
Hz), 3.81 (dd, 1H, J 8.7, 10.2 Hz), 3.71 (s, 3H), 3.63 (dd, 1H, J 5.7, 10.2 Hz), 3.60-3.56 (m, 2H), 1.91-
1.71 (m, 2H); 13C NMR  159.2 (C, Ar), 157.3 (CO), 137.8 (C, Ar), 133.9 (CH), 133.5 (CH), 130.2 
(C, Ar), 129.3 (CH, Ar), 128.4 (CH, Ar), 127.8 (CH, Ar), 127.7 (CH, Ar), 120.9 (CH2), 118.5 (CH2), 
113.8 (CH, Ar), 74.4 (CH), 72.9 (CH2), 72.9 (CH2), 68.8 (CH2), 65.8 (CH2), 61.5 (CH), 56.2 (CH), 
55.2 (CH3), 31.0 (CH2); MS (CI +ve) m/z 438 (M+1
+); HRMS (EI +ve) Calcd for C26H31NO5 (M
+) 
437.2202. Found: 437.2184. 
 
 (-)-(1R,5R,6R,7S,7aR)–1-[2-(4-Methoxyphenyl)methoxy]ethyl-5-(phenylmethoxy)methyl-5,7a-
dihydro-1H,3H-pyrrolo[1,2-c]oxazol-3-one (14) 
Grubbs’ Catalyst I (245 mg, 0.298 mmol) was added to a solution of 13 (520 mg, 1.190 mmol) in dry 
DCM (600 mL) under nitrogen. The mixture was heated at reflux under nitrogen for 24 h. TLC 
analysis (35% EtOAc/petrol) indicated incomplete conversion of compound 13. Additional Grubbs’ 
Catalyst I (245 mg, 0.298 mmol) was added and the reaction was continued under the same conditions 
for another 24 h. The reaction mixture was cooled and then the solvent was removed in vacuo to give a 
brown oil which was purified by column chromatography (20%-70% EtOAc/petrol) to give 14 (358 
mg, 73%) as a clear oil.  []D24 -90.3 (c 2.4, CHCl3); 1H NMR  7.36-7.21 (m, 7H), 6.87 (d, 1H, J 8.7 
Hz), 6.02 (ddd, 1H, J 1.8, 1.8, 6.0 Hz), 5.91 (ddd, 1H, J 1.8, 1.8, 6.0 Hz), 4.92 (ddd, 1H, J 4.2, 8.4, 8.7 
14 
Hz), 4.83-4.78 (m, 2H), 4.56 (s, 2H), 4.45 (d, 1H, J 11.4 Hz), 4.41 (d, 1H, J 11.4 Hz), 3.79 (s, 3H), 
3.62-3.53 (m, 4H), 1.92 (dddd, 1H, J 4.5, 6.9, 8.1, 14.4 Hz), 1.78 (dddd, 1H, J 4.5, 4.8, 8.7, 14.4 Hz); 
13C NMR  162.2 (CO), 159.2 (C, Ar), 137.9 (C, Ar), 132.9 (CH), 130.0 (C, Ar), 129.3 (CH, Ar), 
128.3 (CH, Ar), 128.1 (CH), 127.6 (CH, Ar), 127.5 (CH, Ar), 113.8 (CH, Ar), 76.4 (CH), 73.2 (CH2), 
73.0 (CH2), 71.1 (CH2), 68.2 (CH), 66.8 (CH), 65.8 (CH2), 55.2 (CH3), 32.5 (CH2); MS (CI +ve) m/z 
410 (M+1+); HRMS (CI +ve) Calcd for C24H28NO5 (MH
+) 410.1967. Found: 410.1958. 
 
 (-)-(1R,5R,6R,7S,7aR)–1-[2-(4-Methoxyphenyl)methoxy]ethyl-5-(phenylmethoxy)methyl-
5,6,7,7a-tetrahydro-6,7-dihydroxy-1H,3H-pyrrolo[1,2-c]oxazol-3-one (15).  To a solution of 14 
(327 mg, 0.800 mmol) in acetone (6 mL) were added water (4 mL), 4-morpholine N-oxide (206 mg, 
1.759 mmol) and potassium osmate dihydrate (14.7 mg, 0.040 mmol). The mixture was stirred at RT 
for 24 h. Then all volatiles were removed in vacuo. The residue was dissolved in toluene and 
evaporated to dryness in vacuo to give a dark semi-solid which was chromatographed on silica gel 
eluating with 2.5%-7.5% methanol/DCM affording compound 15 as a brown oil (191 mg, 82%). 
[]D24 -43.9 (c 2.2, CHCl3);  1H NMR  7.35-7.28 (m, 5H), 7.22 (d, 2H, J 8.4 Hz), 6.86 (d, 2H, J 8.7 
Hz), 4.80 (dt, 1H, J 5.4, 7.8 Hz), 4.59 (d, 1H, J 12.0 Hz), 4.54 (d, 1H, J 12.0 Hz), 4.44 (d, 1H, J 12.3 
Hz), 4.40 (d, 1H, J 12.0 Hz), 4.31 (dd, 1H, J 3.3, 6.3 Hz), 4.00 (t, 1H, J 2.7 Hz), 3.80-3.53 (m, 6H), 
3.79 (s, 3H), 2.48-2.38 (m, 1H), 2.26-2.15 (m, 1H); 13C NMR (one Ar C could not be observed)  
162.6 (CO), 137.8 (C, Ar), 130.1 (C, Ar), 129.3 (CH, Ar), 128.5 (CH, Ar), 127.8 (CH, Ar), 127.6 (CH, 
Ar), 113.8 (CH, Ar), 76.4 (CH), 74.1 (CH), 73.5 (CH2), 72.9 (CH2), 72.3 (CH), 70.4 (CH2), 66.4 
(CH2), 65.0 (CH), 62.3 (CH), 55.2 (CH3), 30.8 (CH2); MS (CI +ve) m/z 444 (M+1
+); HRMS (EI +ve) 
Calcd for C24H29NO7 (M
+) 443.1944. Found: 443.1926. 
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 (-)-(1R,5R,6R,7S,7aR)–6,7-Diacetoxy-1-[2-(4-methoxyphenyl)methoxy]ethyl-5-
(phenylmethoxy)methyl-5,6,7,7a-tetrahydro-1H,3H-pyrrolo[1,2-c]oxazol-3-one (16).  Compound 
15 (170 mg, 0.384 mmol) was dissolved in pyridine (2.0 mL) and then Ac2O (2.0 mL) was added. The 
mixture was stirred at RT for 20 h, then diluted with DCM (40 mL) and washed with saturated 
NaHCO3 solution at 0 
0C. The aqueous portion was extracted with DCM (3x). The combined organic 
portions were dried (MgSO4), filtered and evaporated in vacuo to give an oil which was purified by 
column chromatography (30%-70% EtOAc/petrol) to give product 16 as a colorless oil (154 mg, 
76%).  []D26 -4.3 (c 2.0, CHCl3); 1H NMR (500 MHz)  7.35-7.26 (m, 5H), 7.22 (d, 2H, J 8.5 Hz), 
6.87 (d, 2H, J 8.5 Hz), 5.53 (dd, 1H, J 3.0, 7.5 Hz), 5.46-5.45 (m, 1H), 4.82 (ddd, 1H, J 7.0, 7.0, 14.0 
Hz), 4.60 (d, 1H, J 12.0 Hz), 4.54 (d, 1H, J 12.0 Hz), 4.42 (s, 2H), 3.96 (dt, 1H, J 7.0, 3.5 Hz), 3.92 
(dd, 1H, J 2.0, 7.5 Hz), 3.71 (dd, 1H, J 3.5, 10.5 Hz), 3.61 (dd, 1H, J 3.0, 10.5 Hz), 3.58-3.51 (m, 2H), 
2.10 (s, 3H), 2.07-2.01 (m, 1H), 1.99-1.89 (m, 1H), 1.97 (s, 3H); 13C NMR  169.6 (CO), 169.4 (CO), 
161.2 (CO), 159.2 (C, Ar), 137.6 (C, Ar), 129.7 (C, Ar), 129.2 (CH, Ar), 128.3 (CH, Ar), 127.6 (CH, 
Ar), 127.4 (CH, Ar), 113.7 (CH, Ar), 73.8 (CH), 73.4 (CH), 73.3 (CH2), 72.8 (CH2), 72.6 (CH), 69.0 
(CH2), 65.6 (CH2), 63.2 (CH), 59.7 (CH), 55.1 (CH3), 29.6 (CH2), 20.7 (CH3), 20.2 (CH3); MS (CI 
+ve) m/z 528 (M+1+); HRMS (ES +ve) Calcd for C28H34NO9 (MH
+) 528.2234. Found: 528.2238. 
 
 (+)-(1R,5R,6R,7S,7aR)–6,7-Diacetoxy-1-(2-hydroxy)ethyl-5-(phenylmethoxy) methyl-5,6,7,7a-
tetrahydro-1H,3H-pyrrolo[1,2-c]oxazol-3-one (17). To a solution of 16 (150 mg, 0.285 mmol) in 
dichloromethane (25 mL) and water (2 mL) was added 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) 
(90.5 mg, 0.399 mmol). After the mixture had stirred at RT for 3 h, TLC analysis (70% EtOAc/petrol) 
indicated the presence of compound 16. Additional DDQ (38.8 mg, 0.171 mmol) was then added to 
the mixture. The reaction was continued for another 2 h. The mixture was diluted with water (50 mL) 
16 
and extracted with DCM (3x). The combined organics were dried (MgSO4) and filtered and the 
solvent was removed under reduced pressure to give a red semi-solid that was purified by column 
chromatography (30%-80% EtOAc/petrol) to give the product 17 as a colorless oil (102 mg, 88%).  
[]D25 +15.9 (c 1.4, CHCl3); 1H NMR  7.38-7.26 (m, 5H), 5.57 (dd, 1H, J 3.6, 7.5 Hz), 5.52-5.50 (m, 
1H), 4.86 (ddd, 1H, J 6.0, 7.8, 7.8 Hz), 4.61 (d, 1H, J 12.0 Hz), 4.55 (d, 1H, J 12.0 Hz), 4.04 (dd, 1H, 
J 2.1, 7.5 Hz), 3.98 (dt, 1H, J 7.2, 3.3 Hz), 3.86-3.77 (m, 2H), 3.73 (dd, 1H, J 3.3, 10.2 Hz), 3.63 (dd, 
1H, J 3.3, 10.2 Hz), 2.12 (s, 3H), 2.08-1.98 (m, 1H), 1.98 (s, 3H), 1.93-1.82 (m, 1H); 13C NMR  
169.9 (CO), 169.7 (CO), 161.4 (CO), 137.7 (C, Ar), 128.4 (CH, Ar), 127.7 (CH, Ar), 127.5 (CH, Ar), 
73.9 (CH), 73.8 (CH), 73.4 (CH2), 72.7 (CH), 69.0 (CH2), 63.4 (CH), 59.9 (CH), 59.1 (CH2), 31.8 
(CH2), 20.8 (CH3), 20.4 (CH3); MS (CI +ve) m/z 408 (M+1
+, 100%); HRMS (ES +ve) Calcd for 
C20H26NO8 (MH
+) 408.1658. Found: 408.1657. 
 
Three Step Synthesis of (-)-(1S,2R,3R,7R,7aR)–1,2,7-Triacetoxy-3-
(phenylmethoxy)methylhexahydro-1H-pyrrolizine (20) from 17.  To a solution of 17 (101 mg, 
0.248 mmol) in ethanol (4 mL) was added sodium hydroxide (99.3 mg, 2.482 mmol). The reaction 
was heated at 70 0C in a sealed tube for 24 h. The volatiles were then removed in vacuo to give a 
yellow-green solid, and the residue was treated with 2M hydrochloric acid (3 mL). All the volatiles 
were removed in vacuo to give a yellow solid that was purified by acidic ion-exchange 
chromatography to give the desired compound 18 (ca 100 mg) as a yellow solid. This compound 
appeared pure by NMR analysis but from the mass recovery (>100%) this material was believed to 
contain salts. Spectral data for 18: 1H NMR (CD3OD)  7.43-7.26 (m, 5H), 5.07 (bs, 1H, OH), 4.67 (d, 
1H, J 11.7 Hz), 4.62 (d, 1H, J 11.7 Hz), 4.38 (t, 1H, J 3.3 Hz), 4.25 (dd, 1H, J 3.3, 8.7 Hz), 4.22-4.17 
(m, 1H), 3.88 (dd, 1H, J 3.3, 10.8 Hz), 3.84-3.71 (m, 4H), 3.55 (dd, 1H, J 2.7, 7.5 Hz), 1.96-1.75 (m, 
17 
2H); 13C NMR (CD3OD)  138.8 (C, Ar), 129.4 (CH, Ar), 129.0 (CH, Ar), 128.9 (CH, Ar), 74.3 (CH), 
73.1 (CH), 71.9 (CH), 67.9 (CH2), 66.0 (CH), 65.5 (CH), 62.6 (CH), 59.1 (CH2), 37.5 (CH2); []D26 
+18.1 (c 1.8, MeOH); MS (CI +ve) m/z 298 (M+1+, 100%); HRMS (ES +ve) Calcd for C15H24NO5 
(MH+) 298.1654. Found: 298.1645. To a stirred mixture of 18 obtained above, triphenylphosphine 
(111 mg, 0.424 mmol) and anhydrous pyridine (4 mL) at 0 0C was added dropwise diisopropyl 
azodicarboxylate (83.5 L, 0.424 mmol) under nitrogen. The mixture was stirred at 0 0C for 2.5 h. The 
volatiles were removed in vacuo then 1M hydrochloric acid (15 mL) was added. The solution was 
concentrated in vacuo to give a yellow solid, which was purified by acidic ion-exchange 
chromatography to give compound 19.  This material was dissolved in pyridine (2.0 mL) and then 
Ac2O (2.0 mL) was added. The mixture was stirred at RT for 24 h, and then diluted with DCM (25 
mL) and washed with saturated NaHCO3 solution. The aqueous portion was extracted with DCM (3x) 
and the combined organic extracts were dried (MgSO4), filtered and evaporated in vacuo to give a 
solid. Purification by column chromatography (30%-70% EtOAc/petrol) gave product 20 (19.4 mg, 
20% overall for 3 steps) as a colorless oil.  []D27 -5.1 (c 1.0, CHCl3); 1H NMR  7.36-7.27 (m, 5H), 
5.48 (t, 1H, J 4.5 Hz), 5.20-5.15 (m, 2H), 4.58 (d, 1H, J 12.0 Hz), 4.51 (d, 1H, J 12.0 Hz), 3.66 (dd, 
1H, J 3.6, 4.5 Hz), 3.55 (dd, 1H, J 4.2, 9.6 Hz), 3.47 (dd, 1H, J 5.7, 9.9 Hz), 3.29 (ddd, 1H, J 6.6, 6.9, 
10.8 Hz), 3.04 (ddd, 1H, J 4.2, 5.7, 9.6 Hz), 2.89 (ddd, 1H, J 6.3, 6.6, 10.8 Hz), 2.26-1.88 (m, 2H), 
2.10 (s, 3H), 2.02 (s, 3H), 1.95 (s, 3H); 13C NMR  170.6 (CO), 169.7 (CO), 169.5 (CO), 138.1 (C, 
Ar), 128.3 (CH, Ar), 127.6 (CH, Ar), 127.5 (CH, Ar), 74.0 (CH), 73.9 (CH), 73.4 (CH2), 71.5 (CH), 
71.4 (CH2), 69.5 (CH), 65.8 (CH), 53.2 (CH2), 32.3 (CH2), 21.0 (CH3), 20.8 (CH3), 20.5 (CH3); MS 
(CI +ve) m/z 406 (M+1+, 100%); HRMS (ES +ve) Calcd for C21H28NO9 (MH
+) 406.1866. Found: 
406.1860. 
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 (+)-(1S,2R,3R,7R,7aR)–1,2,7-Triacetoxy-3-(acetoxymethyl)hexahydro-1H-pyrrolizine (22).  To a 
solution of 20 (19.4 mg, 0.048 mmol) in methanol (1 mL) was added palladium chloride (7.3 mg, 
0.041 mmol). The mixture was stirred under an atmosphere of hydrogen at RT for 1 h. The mixture 
was then filtered through a plug of cotton wool and the solvent was removed under reduced pressure 
to give the title product 21 as a pale yellow oil. This oil was then dissolved in pyridine (0.5 mL) and 
Ac2O (0.5 mL) was added to the solution. The mixture was stirred at RT for 18 h, then diluted with 
DCM (25 mL) and washed with saturated NaHCO3 solution. The aqueous portion was extracted with 
DCM (3x). The combined organic portions were dried (MgSO4), filtered and evaporated in vacuo to 
give a solid which was purified by column chromatography (30%-70% EtOAc/petrol) to give 
compound 22 as a pale yellow oil (14.4 mg, 84% overall for 2 steps).  []D25 +10.5 (c 1.4, CHCl3);  1H 
NMR  5.48 (dd, 1H, J 3.9, 4.2 Hz), 5.18 (ddd, 1H, J 3.9, 5.4, 9.6 Hz), 5.12 (dd, 1H, J 3.9, 9.3 Hz), 
4.18 (dd, 1H, J 4.2, 11.4 Hz), 4.03 (dd, 1H, J 5.7, 11.4 Hz), 3.64 (dd, 1H, J 3.9, 4.2 Hz), 3.26 (ddd, 
1H, J 6.6, 6.6, 10.5 Hz), 3.08 (ddd, 1H, J 4.2, 5.4, 9.3 Hz), 2.83 (ddd, 1H, J 6.6, 6.9, 10.5 Hz), 2.28-
1.92 (m, 2H), 2.12 (s, 3H), 2.07 (s, 3H), 2.02 (s, 3H), 2.00 (s, 3H); 13C NMR  170.7 (CO), 170.6 
(CO), 169.6 (CO), 169.4 (CO), 73.9 (CH), 73.7 (CH), 71.3 (CH), 69.5 (CH), 64.9 (CH2), 64.6 (CH), 
53.0 (CH2), 32.4 (CH2), 20.9 (CH3), 20.80 (CH3), 20.7 (CH3), 20.4 (CH3); MS (CI +ve) m/z 358 
(M+1+, 100%); HRMS (ES +ve) Calcd for C16H24NO8 (MH
+) 358.1502. Found: 358.1507. 
 
 (+)-(1S,2R,3R,7R,7aR)–Hexahydro–3-hydroxymethyl–1H-pyrrolizine-1,2,7-triol, [(+)-1,7-
Diepiaustraline] (8).  To a solution of 22 (14.4 mg, 0.040 mmol) in dry methanol (1 mL) was added 
the solution of sodium methoxide (0.087M, 46 μL, 0.004 mmol). The mixture was stirred under 
nitrogen at RT for 20 h. Then all the volatiles were removed in vacuo to give compound 8 as a 
colorless oil (7.0 mg, 92%). []D24 +6.4 (c 0.7, MeOH), []D24 +8.6 (c 0.7, H2O) [lit9c []D20 +4.7 (c 
19 
0.5, H2O)]; 
1H NMR (500MHz, CD3OD)  4.55 (dt, 1H, J 3.5, 5.5 Hz), 4.02 (t, 1H, J 4.0 Hz), 3.80 
(dd, 1H, J 4.0, 9.5 Hz), 3.76 (dd, 1H, J 3.5, 11.0 Hz), 3.56 (dd, 1H, J 6.5, 11.5 Hz), 3.26 (t, 1H, J 4.0 
Hz), 3.18 (ddd, 1H, J 6.5, 6.5, 11.0 Hz), 2.79-2.71(m, 2H), 2.12-2.06 (m, 1H), 1.79-1.73(m, 1H); 13C 
NMR (CD3OD)  76.1 (CH), 74.7 (CH), 71.9 (CH), 71.8 (CH), 70.7 (CH), 64.2 (CH2), 54.2 (CH2), 
36.1 (CH2); MS (CI +ve) m/z 190 (M+1
+, 100%); HRMS (ES +ve) Calcd for C8H16NO4 (MH
+) 
190.1079. Found: 190.1099.  
 
 (-)-(3aS,3bR,4R,8R,8aR)-4-[2-(4-Methoxyphenyl)methoxy]ethyl-8-
phenylmethoxylmethyltetrahydro-3aH-[1,3,2]dioxathiolo[4’,5’:3,4]pyrrolo[1,2-c][1,3]oxazol-6-
one 2,2-dioxide (23).  To a solution of 22 (34.2 mg, 0.077 mmol) in DCM (1 mL) was added Et3N 
(24.8 L, 0.178 mmol) followed by thionyl chloride (7.1 L, 0.097 mmol) at 0 0C. The mixture was 
stirred for 20 min at 0 0C and water (2 mL) was added to the mixture. The aqueous layer was extracted 
with DCM (3x). The combined organic phases were dried (MgSO4), filtered and evaporated under 
reduced pressure to give a brown oil. The crude cyclic sulfite was used in the next step without the 
further purification.  []D25 –21.3 (c 0.3, CHCl3); 1H NMR  7.40-7.32 (m, 3H), 7.26 (dd, 2H, J 2.1, 
8.1 Hz), 7.20 (d, 2H, J 8.7 Hz), 6.85 (d, 2H, J 9.0 Hz), 5.50 (dd, 1H, J 2.1, 5.1 Hz), 5.38 (dd, 1H, J 
3.3, 5.1 Hz), 4.90 (dd, 1H, J 7.2, 14.1 Hz), 4.58 (d, 1H, J 12.0 Hz), 4.48 (d, 1H, J 12.0 Hz), 4.43 (s, 
2H), 4.28 (dd, 1H, J 3.0, 6.9 Hz), 4.19 (bdd, 1H, J 3.0, 5.1 Hz), 3.79 (s, 3H), 3.73 (dd, 1H, J 2.7, 9.6 
Hz), 3.69-3.55 (m, 3H), 2.42-2.24 (m, 2H); 13C NMR (CO could not be observed)  159.3 (C, Ar), 
137.1 (C, Ar), 129.8 (C, Ar), 129.4 (CH, Ar), 128.7 (CH, Ar), 128.2 (CH, Ar), 127.7 (CH, Ar), 113.9 
(CH, Ar), 88.4 (CH), 85.2 (CH), 74.6 (CH), 73.7 (CH2), 73.1 (CH2), 71.1 (CH2), 66.2 (CH2), 65.5 
(CH), 63.7 (CH), 55.3 (CH3), 29.5 (CH2); MS (CI +ve) m/z 370 (M-PMB+2
+); HRMS (ES +ve) Calcd 
for C24H28NO8 (MH
+) 490.1536. Found: 490.1531.  The crude cyclic sulfite obtained above was 
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dissolved in 1.75 mL of a solution of CCl4: CH3CN: H2O (2: 2: 3, v/v/v) and RuCl3
.3H2O (1.1 mg, 
0.0042 mmol) was added followed by NaIO4 (31.4 mg, 0.1467 mmol). The mixture was stirred at RT 
for 1.5 h and then diluted with ethyl ether (5 mL). The organic layer was filtered through a pad of 
celite. The filtrate was washed with water and saturated sodium bicarbonate solution followed by brine 
and then dried (MgSO4). The solvent was evaporated and then chromatography of the residue, eluting 
with EtOAc/petrol (40%-70%), gave compound 23 (31.1 mg, 80%) as a pale yellow oil.  []D26 -14.6 
(c 1.5, CHCl3);  
1H NMR  7.40-7.33 (m, 3H), 7.24 (dd, 2H, J 1.5, 8.1 Hz), 7.17 (d, 2H, J 8.4 Hz), 
6.84 (d, 2H, J 8.7 Hz), 5.36 (dd, 1H, J 1.8, 5.4 Hz), 5.21 (dd, 1H, J 3.0, 5.1 Hz), 4.88 (dt, 1H, J 6.6, 
7.8 Hz), 4.56 (d, 1H, J 11.7 Hz), 4.46 (d, 1H, J 11.7 Hz), 4.45-4.40 (m, 3H), 4.19 (dd, 1H, J 3.0, 7.2 
Hz), 3.78 (s, 3H), 3.74 (dd, 1H, J 3.0, 9.9 Hz), 3.67 (dd, 1H, J 3.0, 9.9 Hz), 3.70-3.64 (m, 1H), 3.57 
(dt, 1H, J 3.3, 10.2 Hz), 2.40-2.17 (m, 2H); 13C NMR (CO could not be observed)  159.4 (C, Ar), 
136.8 (C, Ar), 129.6 (C, Ar), 129.5 (CH, Ar), 128.7 (CH, Ar), 128.3 (CH, Ar), 127.7 (CH, Ar), 113.9 
(CH, Ar), 87.3 (CH), 85.4 (CH), 74.8 (CH), 73.8 (CH2), 73.2 (CH2), 70.8 (CH2), 66.1 (CH2), 65.8 
(CH), 62.7 (CH), 55.2 (CH3), 29.3 (CH2); []D26 -14.6 (c 1.5, CHCl3); MS (CI +ve) m/z 386 (M-
PMB+2+); HRMS (ES +ve) Calcd for C24H28NO9S (MH
+) 506.1485. Found: 506.1505; Calcd for 
C24H27NO9NaS (M+Na
+) 528.1304. Found: 528.1318.  
 
 (+)-(1R,5R,6R,7R,7aR)-6-Hydroxyl-1-[2-(4-methoxyphenyl)methoxy]ethyl-7-phenylcarbonyloxy-
5-phenylmethoxymethyltetrahydro-1H-pyrrolo[1,2-c][1, 3]oxazol-3-one (24).  To a solution of 23 
(158 mg, 0.312 mmol) in DMF (5 mL) was added benzoic acid (64.7 mg, 0.530 mmol) followed by 
cesium carbonate (152 mg, 0.468 mmol). The mixture was stirred under nitrogen at 40 0C for 4 h. 
DMF was removed under reduced pressure and the residue was suspended in THF (6 mL). Water (6 
drops) followed by concentrated sulfuric acid (3 drops) was added and the suspension became a clear 
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solution. The solution was stirred at RT for 22 h. The volatiles were removed in vacuo to give a semi-
solid which was purified by column chromatography (20%-60% EtOAc/petrol) to give 24 (95.3 mg, 
56%) as a colourless oil.  []D25 +40.0 (c 1.8, CHCl3); 1H NMR  7.95 (dd, 2H, J 1.2, 8.4 Hz), 7.63-
7.56 (m, 1H), 7.48-7.41 (m, 2H), 7.35-7.25 (m, 5H), 7.21 (d, 2H, J 8.7 Hz), 6.84 (d, 2H, J 8.7 Hz), 
5.16 (dd, 1H, J 4.8, 7.8 Hz), 4.98 (ddd, 1H, J 3.9, 7.8, 11.7 Hz), 4.63-4.52 (m, 1H), 4.61 (d, 1H, J 12.0 
Hz), 4.54 (d, 1H, J 12.6 Hz), 4.42 (d, 1H, J 11.4 Hz), 4.37 (d, 1H, J 11.4 Hz), 4.26 (t, 1H, J 7.8 Hz), 
4.14 (apparent q, 1H, J 4.2 Hz), 3.79-3.74 (m, 1H), 3.77 (s, 3H), 3.71 (dd, 1H, J 2.4, 4.2 Hz), 3.62-
3.58 (m, 2H), 2.10-1.88 (m, 2H); 13C NMR (one Ar C could not be observed)  166.8 (CO), 160.5 
(CO), 159.2 (C, Ar), 137.7 (C, Ar), 133.8 (CH, Ar), 129.9 (C, Ar), 129.7 (CH, Ar), 129.4 (CH, Ar), 
128.6 (CH, Ar), 128.3 (CH, Ar), 127.7 (CH, Ar), 127.5 (CH, Ar), 113.8 (CH, Ar), 79.8 (CH), 79.3 
(CH), 73.3 (CH2), 72.9 (CH2), 70.0 (CH2), 65.6 (CH2), 64.6 (CH), 64.5 (CH), 55.2 (CH3), 30.8 (CH2); 
MS (ES +ve) m/z 570 (M+Na+, 100%); HRMS (ES +ve) Calcd for C31H34NO8 (MH
+) 548.2284. 
Found: 548.2350; Calcd for C31H33NO8Na (M+Na
+) 570.2104. Found: 570.2164. 
 
 (+)-(1R,5R,6R,7R,7aR)-6-Hydroxyl-1-(2-hydroxy)ethyl-7-phenylcarbonyloxy-5-
(phenylmethoxy)methyl-tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-one (25).  The same procedure 
described above for the preparation of 17 was used starting with 24 (30.6 mg, 0.056 mmol) and DDQ 
(15.2 mg, 0.067 mmol) in a solution of DCM (5 mL) containing water (0.5 mL). Compound 25 (17.9 
mg, 75%) was obtained as a pale yellow oil.  []D28 +56.9 (c 1.5, CHCl3); 1H NMR  7.98 (ddd, 2H, J 
0.6, 1.2, 7.8 Hz), 7.62 (tt, 1H, J 1.5, 7.5 Hz), 7.46 (t, 2H, J 7.8 Hz), 7.32-7.29 (m, 5H), 5.14 (dd, 1H, J 
4.8, 7.8 Hz), 4.97 (bdd, 1H, J 7.5, 13.8 Hz), 4.62 (d, 1H, J 11.7 Hz), 4.56 (d, 1H, J 12.0 Hz), 4.64-4.54 
(m, 1H), 4.29 (t, 1H, J 8.1 Hz), 4.13 (bdd, 1H, J 4.2, 8.1 Hz), 3.87-3.78 (m, 2H), 3.74 (dd, 1H, J 4.2, 
9.9 Hz), 3.69 (dd, 1H, J 4.5, 9.9 Hz), 2.04-1.96 (m, 2H); 13C NMR  167.1 (CO), 160.4 (CO), 137.7 
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(C, Ar), 134.0 (CH, Ar), 129.8 (CH, Ar), 128.7 (CH, Ar), 128.6 (C, Ar), 128.4 (CH, Ar), 127.8 (CH, 
Ar), 127.6 (CH, Ar), 80.1 (CH), 79.4 (CH), 73.4 (CH2), 73.3 (CH), 70.1 (CH2), 64.8 (CH), 64.7 (CH), 
59.0 (CH2), 33.0 (CH2); MS (CI +ve) m/z 428 (M+1
+, 100%); HRMS (EI +ve) Calcd for C23H25NO7 
(M-1+) 426.1553. Found: 426.1514. 
 
 (+)-(2R,3R,4R,5R)-5-[(1R)-1,3-Dihydroxypropyl]-2-(phenylmethoxy)methyl pyrrolizine-3,4-diol 
(26).  The same procedure described above for the preparation of 18 was used starting with 25 (48.6 
mg, 0.114 mmol) and sodium hydroxide (45.5 mg, 1.138 mmol) in a solution of ethanol (1 mL). 
Compound 26 (20.5 mg, 61%) was obtained as a pale yellow oil.  []D29 +14.0 (c 2.1, MeOH); 1H 
NMR (D2O)  7.57-7.44 (m, 5H), 4.66 (bs, 2H), 4.13 (t, 1H, J 6.9 Hz), 3.98-3.93 (m, 2H), 3.81-3.66 
(m, 4H), 3.34 (bs, 1H), 3.12 (bs, 1H), 1.87-1.75 (m, 2H); 13C NMR (CD3OD)  139.1 (C, Ar), 129.5 
(CH, Ar), 129.0 (CH, Ar), 128.9 (CH, Ar), 78.5 (CH), 76.9 (CH), 74.4 (CH2), 69.3 (CH2), 69.0 (CH), 
66.5 (CH), 63.1 (CH), 59.5 (CH2), 37.1 (CH2); MS (CI +ve) m/z 298 (M+1
+, 100%); HRMS (ES +ve) 
Calcd for C15H24NO5 (MH
+) 298.1654. Found: 298.1661. 
 
 (+)-(1R,2R,3R,7R,7aR)–1,2,7-Triacetoxy-3-(phenylmethoxy)methylhexahydro-1H-pyrrolizine 
(28).  The same procedure described above for the preparation of 19 was used using DIAD (16.3 L, 
0.083 mmol) and Ph3P (21.7 mg, 0.083 mmol) and 26 (20.5 mg, 0.069 mmol) in dry THF (1 mL). 
Compound 27 was obtained as a pale yellow oil. Acetylation of 27, using the same procedure 
described above for the preparation of 20 gave the title compound 28 (6.3 mg, 22% overall for 2 steps) 
as a pale yellow oil.  []D29 +18.5 (c 0.6, CHCl3);  1H NMR  7.36-7.27 (m, 5H), 5.29 (dd, 1H, J 6.3, 
6.9 Hz), 5.21 (dt, 1H, J 6.0, 3.0 Hz), 5.11 (dd, 1H, J 6.0, 6.3 Hz), 3.56-3.47 (m, 2H), 3.38 (dd, 1H, J 
3.0, 6.0Hz), 3.19 (ddd, 1H, J 6.0, 9.3, 11.7 Hz), 3.01-2.94 (m, 2H), 2.19-2.04 (m, 1H), 2.05 (s, 3H), 
23 
2.02 (s, 3H), 1.99 (s, 3H), 1.89-1.80 (m, 2H); 13C NMR (one Ar C could not be observed)  170.2 
(CO), 170.1 (CO), 169.6 (CO), 127.9 (CH, Ar), 127.2 (CH, Ar), 127.2 (CH, Ar), 77.3 (CH), 76.8 
(CH), 76.1 (CH), 73.0 (CH2), 72.5 (CH), 71.4 (CH2), 66.7 (CH), 52.2 (CH2), 29.7 (CH2), 20.6 (CH3), 
20.5 (CH3), 20.4 (CH3); MS (CI +ve) m/z 406 (M+1
+, 100%); HRMS (ES +ve) Calcd for C21H28NO7 
(MH+) 406.1866. Found: 406.1858. 
 
 
(1R,2R,3R,7R,7aR)–1,2,7-Triacetoxy-3-acetoxymethylhexahydro-1H-pyrrolizine (30).  A solution 
of compound 28 (5.2 mg, 0.013 mmol) in MeOH (0.5 mL) was treated with palladium chloride (2.0 
mg, 0.011 mmol) as described above for the preparation of 20. The product 29 was acetylated using 
pyridine (0.5 mL) and Ac2O (0.5 mL) as described above for the synthesis of 21. Compound 30 (4.3 
mg, 94% overall for 2 steps) was obtained as a pale yellow oil.  1H NMR  5.22 (t, 1H, J 5.4 Hz), 
5.22-5.19 (m, 1H), 5.16 (t, 1H, J 5.4 Hz), 4.11 (bd, 1H, J 1.2 Hz), 4.09 (bd, 1H, J 1.2 Hz), 3.39 (dd, 
1H, J 3.0, 5.7 Hz), 3.20 (ddd, 1H, J 6.3, 9.0, 11.4 Hz), 3.03 (dd, 1H, J 5.4, 11.7 Hz), 2.91 (ddd, 1H, J 
4.2, 7.5, 11.4 Hz), 2.17-2.09 (m, 1H), 2.09 (s, 6H), 2.06 (s, 3H), 2.04 (s, 3H), 1.91-1.84 (m, 1H); 13C 
NMR  170.8 (CO), 170.6 (CO), 170.3 (CO), 169.8 (CO), 77.8 (CH), 77.5 (CH), 77.1 (CH), 73.1 
(CH), 66.7 (CH), 64.9 (CH2), 52.7 (CH2), 30.3 (CH2), 21.0 (CH3), 20.9 (CH3), 20.8 (CH3); MS (CI 
+ve) m/z 358 (M+1+, 100%.); HRMS (EI +ve) Calcd for C16H24NO8 (MH
+) 358.1502. Found: 
358.1505. 
 
 (-)-(1R,2R,3R,7R,7aR)–Hexahydro–3-hydroxymethyl–1H-pyrrolizine-1,2,7-triol, [(-)-7-
Epiaustraline] (9).  To a solution of 30 (4.3 mg, 0.012 mmol) in methanol (0.5 mL) was added 
potassium carbonate (2.0 mg). The mixture was stirred at RT for 24 h and then concentrated under 
24 
reduced pressure. The residue was dissolved in CHCl3-MeOH (5:1, 6 mL) and filtered though a small 
pad of celite to give the title product 9 (2.2 mg, 97%) as a pale yellow oil.  []D24 -14.1 (c 0.22, H2O) 
[lit6 []D23 –13.04 (c 0.55, H2O, pH 8.37)]; 1H NMR (500 MHz, D2O)  4.18 (dt, 1H, J 5.0, 2.5 Hz), 
3.62 (dd, 1H, J 4.0, 11.5 Hz), 3.55 (t, 1H, J 8.0 Hz), 3.52 (t, 1H, J 8.0 Hz), 3.47 (dd, 1H, J 6.5, 11.5 
Hz), 2.92 (ddd, 1H, J 6.0, 10.0, 11.5 Hz), 2.82 (dd, 1H, J 2.0, 7.5 Hz), 2.70 (ddd, 1H, J 4.0, 7.5, 11.5 
Hz), 2.49 (ddd, 1H, J 4.0, 6.5, 10.0 Hz), 1.91 (dddd, 1H, J 5.5, 7.5, 10.5, 13.0 Hz), 1.63-1.58 (m, 1 H); 
13C NMR (D2O)  77.5 (CH), 76.0 (CH), 74.4 (CH), 73.3 (CH), 67.7 (CH), 62.2 (CH2), 50.9 (CH2), 
30.7 (CH2); MS (CI +ve) m/z 190 (M+1
+); HRMS (ES +ve) Calcd for C8H16NO4 (MH
+) 190.1079. 
Found: 190.1073. 
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